GlassScriptPhysician profile
Hannah M Chalmers
NPI 1891143459
$538.35
in general payments reported to CMS, 2019-2025
13 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.56 · 2022: $41.89 · 2023: $50.61 · 2024: $71.25 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $440.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $136.10 | 2025 | |
| Abbott Laboratories | $87.76 | 2024-2025 | Jot Dx, Allure, Durata |
| Axogen | $58.13 | 2025 | |
| Innocoll Pharmaceuticals Limited | $41.89 | 2022 | |
| Myriad Genetic Laboratories, INC. | $33.69 | 2023 | Myrisk |
| Integra Lifesciences Corporation | $30.56 | 2021 | |
| W. L. Gore & Associates, INC. | $30.53 | 2025 | Gore Synecor Preperitoneal Biomaterial |
| Lilly USA, LLC | $25.00 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $22.45 | 2025 | |
| Dilon Technologies, INC. | $21.81 | 2024 | Hemoblast Bellows |
| Vertex Pharmaceuticals Incorporated | $18.82 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $16.92 | 2023 | Seglentis |
| Abbvie INC. | $14.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Chalmers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.